enVVeno Medical SG&A Expense (Quarterly) Analysis

enVVeno Medical Corp (NVNO)

5.05 -0.01 (-0.20%) USD | NASDAQ | May 03, 16:00

5.10 +0.05 (+0.99%) After-Hours: 20:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2016. Upgrade now.

Date	Value
December 31, 2023	3.297M
September 30, 2023	2.551M
June 30, 2023	2.60M
March 31, 2023	3.202M
December 31, 2022	3.663M
September 30, 2022	3.659M
June 30, 2022	3.913M
March 31, 2022	3.783M
December 31, 2021	7.211M
September 30, 2021	1.482M
June 30, 2021	1.296M
March 31, 2021	1.176M
December 31, 2020	1.881M
September 30, 2020	1.164M
June 30, 2020	0.8397M

Date	Value
March 31, 2020	0.9979M
December 31, 2019	0.9223M
September 30, 2019	1.157M
June 30, 2019	1.532M
March 31, 2019	1.301M
December 31, 2018	1.216M
September 30, 2018	1.105M
June 30, 2018	2.915M
March 31, 2018	1.247M
December 31, 2017	1.657M
September 30, 2017	1.664M
June 30, 2017	1.086M
March 31, 2017	1.050M
December 31, 2016	1.228M
September 30, 2016	0.9588M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

0.8397M

Minimum

Jun 2020

7.211M

Maximum

Dec 2021

2.438M

Average

1.881M

Median

Dec 2020

SG&A Expense (Quarterly) Benchmarks